| A randomized, double-blind, placebo-controlled clinical trial of tocilizumab, an interleukin-6 receptor antibody, for residual symptoms in schizophrenia RR Girgis, A Ciarleglio, T Choo, G Haynes, JM Bathon, S Cremers, ... Neuropsychopharmacology 43 (6), 1317-1323, 2018 | 93 | 2018 |
| Future design of accessibility in games: A design vocabulary P Cairns, C Power, M Barlet, G Haynes International Journal of Human-Computer Studies 131, 64-71, 2019 | 68 | 2019 |
| Enabled Players: The value of accessible digital games P Cairns, C Power, M Barlet, G Haynes, C Kaufman, J Beeston Games and Culture, 1555412019893877, 2019 | 64 | 2019 |
| Validation and Prioritization of Design Options for Accessible Player Experiences C Power, P Cairns, M Barlet, G Haynes, J Beeston, T DeHaven Interacting with Computers 33 (6), 641-656, 2021 | 4 | 2021 |
